Literature DB >> 15246411

Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography.

Hironobu Yanagië1, Koichi Ogura, Kenji Takagi, Kazuo Maruyama, Toshio Matsumoto, Yoshinori Sakurai, Jure Skvarc, Radomir Illic, Guido Kuhne, Tomoyuki Hisa, Iwao Yoshizaki, Kenji Kono, Yoshitaka Furuya, Hirotaka Sugiyama, Hisao Kobayashi, Koji Ono, Keiichi Nakagawa, Masazumi Eriguchi.   

Abstract

The cytotoxic effect of boron neutron capture therapy (BNCT) is due to a nuclear reaction between 10B and thermal neutrons. It is necessary to accumulate the 10B atoms to the tumor cells selectively for effective BNCT. In order to achieve an accurate measurement of 10B concentrations in the biological samples, we employed a technique of neutron capture autoradiography (NCAR) of the sliced whole-body samples of tumor bearing mice using CR-39 plastic track detectors. The CR-39 detectors attached with samples were exposed to thermal neutrons in the thermal column of the TRIGA II reactor at the Institute for Atomic Energy, Rikkyo University and thermal neutron facility of Paul Scherer Institute(PSI). We obtained NCAR images for mice injected intravenously by 10B-PEG liposome, 10B-transferrin-PEG liposome, or 10B-bare liposome. The 10B concentrations in the tumor tissue of mice were estimated by means of alpha-track density measurements. In this study, we can increase the accumulation of 10B atoms in the tumor tissues by binding polyethylene-glycol chains to the surface of liposome, which increase the retention in the blood flow and escape the phagocytosis by reticulo-endothelial systems. Therefore, we will be able to apply NCAR technique for selection of effective 10B carrier in BNCT for cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246411     DOI: 10.1016/j.apradiso.2004.03.109

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

1.  Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.

Authors:  Hironobu Yanagie; Novriana Dewi; Syushi Higashi; Ichiro Ikushima; Koji Seguchi; Ryoji Mizumachi; Yuji Murata; Yasuyuki Morishita; Atsuko Shinohara; Shoji Mikado; Nakahiro Yasuda; Mitsuteru Fujihara; Yuriko Sakurai; Kikue Mouri; Masashi Yanagawa; Tomoya Iizuka; Minoru Suzuki; Yoshinori Sakurai; Shin-Ichiro Masunaga; Hiroki Tanaka; Takehisa Matsukawa; Kazuhito Yokoyama; Takashi Fujino; Koichi Ogura; Yasumasa Nonaka; Hirotaka Sugiyama; Tetsuya Kajiyama; Sho Yui; Ryohei Nishimura; Koji Ono; Sinichi Takamoto; Jun Nakajima; Minoru Ono; Masazumi Eriguchi; Kenichiro Hasumi; Hiroyuki Takahashi
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

2.  Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems.

Authors:  Hironobu Yanagie; Masashi Yanagawa; Yasuyuki Morishita; Atsuko Shinohara; Novriana Dewi; Yasumasa Nonaka; Yoshitaka Furuya; Ryouji Mizumachi; Yuuji Murata; Hiroyuki Nakamura; Minoru Suzuki; Yoshinori Sakurai; Hiroki Tanaka; Shinichiro Masunaga; Koji Ono; Takumichi Sugihara; Masayuki Nashimoto; Haruo Yamauchi; Minoru Ono; Jun Nakajima; Hiroyuki Takahashi
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Antitumour effect of polyoxomolybdates: induction of apoptotic cell death and autophagy in in vitro and in vivo models.

Authors:  A Ogata; H Yanagie; E Ishikawa; Y Morishita; S Mitsui; A Yamashita; K Hasumi; S Takamoto; T Yamase; M Eriguchi
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.